Navigation Links
Dyadic International Reports Third Quarter 2013 Financial Results
Date:11/14/2013

els into the food market and continued growth in the recovering poultry market with our key animal feed customers.

There was no license fee revenue recognized in the third quarter.  The remaining $1.0 million upfront fee for the technology license that was signed with BASF on May 6, 2013 was due upon completion of the technology transfer.  The transfer was completed on October 11, 2013 and the remaining revenue will be recognized in the fourth quarter.  The payment was received on November 5, 2013.

Research and development revenue for the third quarter decreased 50% to $216,000 compared to $427,000 for the third quarter of 2012.  This decrease was due to the delay in the start of certain external research and development projects and the reallocation of research and development resources from externally funded projects to new product development initiatives.  Dyadic is now generating additional research and development revenue from the ongoing research funded by BASF.

Gross profit for the third quarter increased 14% to $691,000 compared to $614,000 for the third quarter last year.  The increase was due primarily to increased product related revenue and the associated margins.  Gross margins as a percent of sales were negatively impacted by changes to the product mix and the decreased research and development revenue, which generally have higher margins. 

Operating expenses for the third quarter increased 44% to $2.0 million compared to $1.4 million for the same period last year.  The increase was due primarily to increased costs associated with litigation against the Company's former outside legal counsel of approximately $514,000.  The increased litigation costs were anticipated and are expected to continue into 2014.

On October 22, 2013, the arbitration proceedings brought by Mr. Emalfarb against the Company were dismissed. In consideration for the dismissal, the Company agreed t
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
2. Dyadic International Launches FibreZyme® G5000 High Performance Powder Pulp and Paper Enzyme in Booth #1065 at Tissue World Americas Conference
3. Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call
4. Dyadic Demonstrates Industry-leading Biofuels Enzyme Performance
5. Dyadic International to Announce Second Quarter 2012 Financial Results and Host Conference Call on Monday, August 13, 2012
6. Dyadic Netherlands To Develop Baking Enzymes For EU-Funded Research Project
7. Dyadic International Reports 2012 Third Quarter Financial Results
8. 12th U.S. Patent Issued To Dyadic International
9. Dyadic International Upgraded By OTC Markets To "Current Information" Tier
10. Dyadic International To Announce Year-End 2012 Financial Results And Host Conference Call On Thursday, March 7, 2013
11. Dyadic International To Present At World Biofuels Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... -- Replikins Ltd. today released new data on changes in ... current outbreaks, the mean Ebola Reston gene Replikin Count ... and 2002 was 1.1; the mean Replikin Count increased ... 2013, thus predicting the current outbreaks in humans. ... to be able to predict outbreaks (1).  For example, ...
(Date:7/30/2014)... Sales Horizons, a leader in sales training ... programs for companies engaged in complex B2B sales. , ... of salespeople over 25 years in market-leading Fortune 500 ... customized to address the unique sales challenges of companies ... program consists of two parts: Mastering the Complex ...
(Date:7/30/2014)... July 30, 2014. Applied DNA Sciences, ... provides DNA-based authentication and security solutions and services, has ... Life Sciences, a newly created position, with a starting ... lead APDN’s drive to build its business in pharmaceuticals ... customers, provide guidance to APDN’s R&D efforts, and apply ...
(Date:7/30/2014)... Yuma Regional Cancer Center Officially ... brings comprehensive cancer care to Yuma, Arizona. , ... Center has officially opened. A Mayo Clinic Care ... such as open, semi-private and private infusion rooms, ... Resource Center, hematology, rehabilitation center, a pain management ...
Breaking Biology Technology:Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3Sate-of-the-Art Yuma Regional Cancer Center Officially Opens 2
... see it, soon you might not, researchers at the ... researchers have demonstrated an approximate cloaking effect created by ... brings scientists a step closer to a practical solution ... a theoretical exercise," said Harley Johnson, a Cannon Faculty ...
... paper titled “Avanta AC™ Advanced Ceramics Solutions ... This white paper outlines the challenges in ... scale, as well as the advantages of ... nanopowders are critical to a variety of ...
... Excellence in Emerging Category, LOS ANGELES, June ... that Dr. Donald Rice, Founder, President, & CEO,received ... 2008 Award in the,Emerging category in the Greater ... the award recognizes outstanding entrepreneurs who are building,and ...
Cached Biology Technology:Silicon photonic crystals key to optical cloaking, researchers say 2 SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles 2Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area 2Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area 3
(Date:7/31/2014)... the photovoltaic effect in 1839, humankind has sought to ... its own purposes. In a new research report published ... FASEB Journal , scientists may have uncovered a ... focusing on a naturally occurring combination of lipids that ... over time and across speciessuggests that this specific natural ...
(Date:7/31/2014)... New Orleans, LA Dr. Oren Tessler, Assistant Professor ... Orleans School of Medicine, is part of a team ... success rate using a method to screen and select ... than 90% of the patients who underwent this surgery ... and also got a bonus cosmetic eyelid surgery. The ...
(Date:7/31/2014)... Florida , July 31, 2014 ... develop unique and innovative smart technologies; companies turn towards ... EBAY ), Amazon.com Inc. (NASDAQ: ... Google Inc. (NASDAQ: GOOG ) and Microsoft ... authentication company focused on the growing m-commerce market, announces ...
Breaking Biology News(10 mins):Scientists shine bright new light on how living things capture energy from the sun 2Surgeons report significant migraine relief from cosmetic eyelid surgery technique 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 3Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 4Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 5Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 6
... has developed a calcium phosphate-based supplement that -- even ... thickness without the side effects of many current drug ... and Biomimetics and of Implant Dentistry, presented her research ... Research annual meeting on March 9, 2006. ...
... Medical Center shows that on a biochemical level, hormone-like ... the way in which certain hormones work in humans ... that afflict a third of the world's population. , ... genes involved in the development and reproduction of Caenorhabditis ...
... "pumps" associated with multi-drug resistance in bacteria may also ... a process known as quorum sensing, said researchers from ... online today in the Proceedings of the National Academy ... by these pumps may actually be similar in structure ...
Cached Biology News:New study reveals promising osteoporosis treatment 2Worm hormone discovery may aid fight against parasitic disease 2Worm hormone discovery may aid fight against parasitic disease 3Drug resistance may travel same path as quorum sensing 2
ANTI DIPHTH TOX A SU...
... EnzChek Lysozyme Assay Kit (E-22013) provides,researchers ... levels of lysozyme,activity in solution. This ... to 20 U/mL (Figure 1). The ... cell,walls, which are labeled to such ...
... is used for the synthesis of 5' ... reactions. Substitution of cap analog for a ... in vitro transcription reaction results in the ... large fraction of the transcripts. Capped mRNAs ...
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. It can incubate up to ...
Biology Products: